Marvell's Rebound Day: What a 9-11% Snapback Really Says About the AI Chip Selloff

Marvell Technology shares surge up to 11% after a $42B selloff, but remain 45% below highs. Strong revenue growth and India expansion offset valuation concerns.

The arithmetic of panic is rarely tidy. After five consecutive sessions of red that erased roughly $42 billion in market value—a 23% slide that dwarfed the S&P 500's 2.4% dip over the same stretch—Marvell Technology shares snapped back hard on Thursday. Depending on the trading venue and the closing print, the bounce landed somewhere between 9.26% and 11%, with the stock settling at €156.24 or €159.00, respectively. Either way, it was the sharpest single-day reversal the chipmaker has managed all year.

That still leaves the stock nursing a 15.11% weekly loss and a 33.43% decline over the trailing 30 days. The shares now sit roughly 45-46% below the 52-week high of €290.35 touched on June 3.

A Company-Specific Problem, Not a Sector-Wide One

The selloff that preceded this bounce was notable for what it wasn't: a broad semiconductor rout. While the wider chip complex has been rattled by fears of Chinese competition—CXMT's Shanghai IPO added fresh fuel to those worries—Marvell's slide was driven by something more specific. The market's expectations around AI data center spending, the trajectory of Marvell's custom silicon programs, and the durability of hyperscaler capital budgets all shifted at once. Macro jitters over interest rates and the broader semis space compounded the pressure.

The bottom came on July 29, when the stock fell 6.3% to $163.40, bringing its monthly decline to 41.2% at that point. The current 30-day figure of 33.43% reflects the partial recovery since.

The Operating Story Hasn't Cracked

Strip away the price action, and the underlying business is still compounding at a clip most S&P 500 constituents would envy. Revenue over the trailing twelve months grew 34.1%—more than four times the index's median of 7.8%. The operating margin of 16.4% trails the sector average of 18.4%, but the growth engine is clearly intact.

That operational strength is part of why the valuation debate has become so heated. GuruFocus calculations put the stock 45.2% above its fair value estimate of $112.57, a red flag for value-minded buyers. Yet the same analysis assigns Marvell a GF Score of 79 out of 100, signaling above-average fundamental strength relative to peers. The tension between those two signals—pricey on paper, strong underneath—is the crux of the current standoff.

Adding to the mixed signals: insiders sold $15.4 million worth of shares over the past three months, with zero insider purchases recorded in the same window.

India Expansion as a Long-Term Signal

While the market was fixated on the slide, Marvell was quietly placing a strategic bet. The company is investing $250 million over three years to expand its R&D footprint in India, with plans to double its headcount across Bangalore and Hyderabad. The move aligns with India's "Semiconductor Mission 2.0" and is aimed squarely at AI chip engineering and data infrastructure—not cost-cutting.

Wolfe Research analysts expect AI chip demand to outpace supply through at least 2028, which lends the India investment a forward-looking logic. Marvell is effectively fortifying its position in 2-nanometer process technology and beyond while competitors scramble to respond to Chinese DUV lithography developments. It's a case of building for the next cycle rather than managing the current one.

Wall Street Isn't Budging

The analyst community has largely held its ground through the turmoil. Of 50 analysts covering the stock, 82% rate it a buy, and average price targets have been revised upward by 101.66% over the past three months. The consensus target sits at €222.92, implying roughly 42.7% upside from current levels.

Institutional positioning tells a more divided story. The California State Teachers Retirement System trimmed its stake by 3.4% in the first quarter, while Amundi increased its position by more than 25%. That divergence captures the broader market debate: is Marvell overpriced at these levels, or is this pullback a rare entry point into a structural AI infrastructure story?

What Happens Next

Technically, the stock is approaching its 100-day moving average of €163.27—a level Thursday's bounce nearly reached. With an RSI of 38 sitting just above oversold territory, the setup suggested a reversal was due even before the snapback.

The next real test comes August 20, 2026, when Marvell reports earnings. The consensus calls for EPS of $0.94 on revenue of $2.76 billion. Those numbers will determine whether the market's five-day, $42 billion reassessment was a necessary correction or an overreaction—and whether the analysts who kept raising their targets through the storm were seeing something the tape wasn't.